Chinese Academy of Sciences invested in a round that will be used to take Haihe's anti-tumour therapies further down the clinical path.

CSPC Pharmaceutical Group and Daehwa Pharmaceutical both invested in a round that will be used to take Haihe's anti-tumour therapies further down the clinical path.

GE’s chief innovation officer and GE Ventures’ CEO, Sue Siegel, has been appointed by Illumina to sit on its board of directors.

Xiaomi-backed smart toothbrush producer Soocas Shenzhen Technology has received almost $30m from investors including Fosun-founded Kinzon Capital.

The General Electric-backed medical device developer has reached a first close of a $15m round that was led by Cormorant and backed by Lilly Asia Ventures.

UL Ventures' parent company will offer assistance in growth and compliance to the healthcare risk assessment platform developer, which has just raised series B funding.

The commercialisation firm will cut cash operating expenses by more than 40% year-on-year, while SciFluor Life and Precision Biopsy received $9m in financing between them.

The UW-founded healthcare forecasting software developer has collected $30.5m in all from backers including OUP and a unit of compliance firm UL.

The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.

Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.